Mice with fibrosarcoma treated with CXCL10 combined with hypothermia presented reduced tumor burden and MVD [50], whereas the MMP2-inhibitor TIMP2, have been recently described as important prognostic factors in acute lymphoblastic leukemia [51]. Here, CXCL10 is linked to fibrosarcoma.